Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia

In conclusion, this study suggests that early administration of convalescent plasma to patients with COVID-19 pneumonia is critical to obtain therapeutic benefit.

Source: Journal of Investigative Medicine - June 22, 2022 Category: Research Authors: Gonzalez, S. E., Regairaz, L., Salazar, M. R., Ferrando, N. S., Gonzalez Martinez, V. V., Carrera Ramos, P. M., Pesci, S. A., Vidal, J. M., Kreplak, N., Estenssoro, E. Tags: COVID-19 Original research Source Type: research